跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Triphimox - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Triphimox
Approved
STANDARD
Triphimox
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9a61c39576fefd7c
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
9a61c39576fefd7c
Drug Approval Philippines Name
Triphimox
Product Name
Triphimox
Registration Number
DR-XY147010
Brand Name
Triphimox
Generic Name
Cotrimoxazole
Dosage Form
Tablet
Dosage Strength
960 mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
Westfield Pharamceuticals, Inc.
Issuance Date
27 August 2020
Expiry Date
27 August 2025
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9a61c39576fefd7c
Type
Standard
Back to Philippines FDA Approvals